. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: Pediatr Infect Dis J. 2013 Nov;32(11):10.1097/INF.0b013e31829e4d06. doi: 10.1097/INF.0b013e31829e4d06

Table 1. Baseline Characteristics and Outcome by Age.

Characteristic		Total (N=998)	Age ≤2 (N=461)	Age >2 (N=537)	P-Value
Gender	male	455 (46%)	213 (46%)	242 (45%)	0.750^*
Gender	female	543 (54%)	248 (54%)	295 (55%)
Race	Black	607 (61%)	284 (62%)	323 (60%)	0.430^*
	Hispanic	247 (25%)	106 (23%)	141 (26%)
	White/Other	144 (14%)	71 (15%)	73 (14%)
Age (years) at randomization	Mean (s.d.)	3.78 (3.84)	0.90 (0.49)	6.25 (3.75)
	Min, Max	0.12, 17.98	0.12, 1.99	2.00, 17.98
	Median	2.34	0.78	5.24
baseline CD4 count/mm³	Mean (s.d.)	978 (838)	1,391 (997)	627 (430)	<.001^**
baseline CD4 count/mm³	Median	775	1,259	583
baseline CD4 percent	Mean (s.d.)	23.7 (12.0)	26.7 (12.4)	21.2 (11.0)	<.001^**
baseline CD4 percent	Median	24.0	26.8	22
baseline plasma HIV RNA copies/ml	Mean (s.d.)	865,899 (2,458,260)	1,669,496 (3,410,391)	177,358 (490,909)	<.001^**
baseline plasma HIV RNA copies/ml	Median	139,738	470,317	53,709
Months of follow-up for progression	Mean (s.d.)	19.36 (10.61)	19.23 (10.35)	19.47 (10.84)	0.868^**
	Min, Max	0.23, 46.71	0.23, 46.71	0.33, 45.92
	Median	18.36	18.19	18.39
Primary endpoint = 1, else 0	0	859 (86%)	372 (81%)	487 (91%)	<.001^*
Primary endpoint = 1, else 0	1	139 (14%)	89 (19%)	50 (9%)
Primary end points(death, opportunistic infection (OI), weight growth failure)	Death	48 (5%)	44 (10%)	4 (1%)
	≥2 OIs	8 (1%)	4 (1%)	4 (1%)
	Weight Growth Failure	83 (8%)	41 (9%)	42 (8%)

Fisher's Exact Test

^**

Wilcoxon Test